Did you know that we have a Twitter page? In addition to company updates, you can view quality and compliance industry updates spanning the pharmaceutical, biotech, medical device, and food and cosmetics sectors.

Here are some recent tweets that you may find of interest.

@US_FDA has extended the comment deadline for the guidance, ICH Q12: Implementation Considerations for FDA-Regulated Products, to Oct. 12. #ICHQ12 #postapprovalchanges

@RAPSorg recently covered remarks from a Perrigo official in an @IPECAMER webinar about questioning #nitrosamine risk assessments.

@MHRAgovuk and the @US_FDA have published their second joint paper on #dataintegrity in #clinicaltrials.

@USPharmacopeia has announced proposed changes to #compounding chapters <795> and <797>. #USP #pharmacopeia #USpharmacopeia #pharmacycompunding

@TheHPRA has released a new guide that supplements the EU GMP Guide on investigations of quality defects. #pharmaGMP #HPRA #pharmaquality

@US_FDA has released the results of the agency’s survey of PFAS in processed foods. #foodsafety

@MedTechDive reports on documents the @EU_Commission released in July and August concerning the #EUMDR and #IVDR.

@US_FDA Office of Pharmaceutical Quality has released its report on the state of pharmaceutical quality in FY2020. #pharmaquality #OPQ #FDA #pharmaGMP

Follow us on Twitter to stay on top of the latest quality and compliance news. You can also follow us on Twitter during our webinars at #RedicaWebinars for live updates.

[Related: Looking for the latest FDA Warning Letters and other regulatory inspection details? Try Redica Systems for free by clicking here.]